Sio Capital Management, LLC Mesoblast LTD Put Options Transaction History

Sio Capital Management, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 15, 2021	SELL	$5.87 - $7.85 $321,676 - $430,180	-54,800 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$6.69 - $9.0 $12,042 - $16,200	-1,800 Reduced 3.18%	54,800 $410,000
Q1 2021 May 14, 2021	SELL	$8.26 - $11.4 $2.98 Million - $4.11 Million	-360,700 Reduced 86.44%	56,600 $468,000
Q4 2020 Feb 16, 2021	SELL	$8.21 - $18.59 $9.41 Million - $21.3 Million	-1,146,000 Reduced 73.31%	417,300 $3.54 Million
Q3 2020 Nov 16, 2020	BUY	$11.33 - $19.81 $10.4 Million - $18.3 Million	922,100 Added 143.81%	1,563,300 $29.1 Million
Q2 2020 Aug 14, 2020	BUY	$4.2 - $15.45 $2.66 Million - $9.78 Million	633,100 Added 7816.05%	641,200 $7.3 Million
Q1 2020 May 15, 2020	BUY	$3.38 - $10.63 $27,378 - $86,103	8,100 New	8,100 $35,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $3.1B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.